Oncology & Cancer

New target for aggressive bladder cancer

An international team of scientists have discovered a faulty process in certain bladder cancers that could point to new ways to treat patients with an aggressive form of the disease.

Oncology & Cancer

Clinical trial could lead to new bladder cancer drug

A bladder cancer drug tested in a University of Hawai'i Cancer Center clinical trial is getting closer to Food and Drug Administration (FDA) approval. The new drug, an interleukin 15 superagonist complex (ALT-803), combined ...

Other

FDA approves Botox competitor that lasts longer

People wanting to keep wrinkles at bay will soon have a new option now that the U.S. Food and Drug Administration has approved the first competitor for Botox in decades.

Medications

Some drugs are going generic this year and next

Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations ...

Oncology & Cancer

Developing a urine test for various types of cancer

Detecting cancer of various types, in a very early stage and using a simple urine sample. That is the ambition of the new startup company NanoMed Diagnostics. Years of research, by scientists of the University of Twente and ...

Health

Cranberry juice now unlikely to prevent cystitis

Cranberry juice is unlikely to prevent bladder and kidney infections, according to an updated systematic review published in The Cochrane Library. The authors analysed the most up-to-date evidence and concluded that any benefit, ...

Oncology & Cancer

Cancer categories recast in largest-ever genomic study

New research partly led by UC San Francisco-affiliated scientists suggests that one in 10 cancer patients would be more accurately diagnosed if their tumors were defined by cellular and molecular criteria rather than by the ...

page 11 from 40